Clinical Trial Update: Dapivirine Gel Rectal Safety and PK Study [Phase 1]

View source ↗

Summary

A Phase 1 safety and pharmacokinetics study of rectal dapivirine gel has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine Gel (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV 1 Infection | Phase 1 | Status: WITHDRAWN